OLANZAPINE DEXCEL 20 MG

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
OLANZAPINE 20 MG
Available from:
DEXCEL PHARMA TECHNOLOGIES LTD
ATC code:
N05AH03
Pharmaceutical form:
TABLETS
Administration route:
PER OS
Manufactured by:
DEXCEL LTD
Therapeutic group:
OLANZAPINE
Therapeutic indications:
Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.
Authorization number:
148113332100
Authorization date:
2012-05-01

Similar products

Search alerts related to this product

Share this information